Cargando…
Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) induces a severe cytokine storm that may cause acute lung injury/acute respiratory distress syndrome (ALI/ARDS) with high clinical morbidity and mortality in infected individuals. Cepharanthine (CEP) is a bisbenzylisoquinoline alkaloid iso...
Autores principales: | Liang, Di, Wang, Wanmei, Chen, Guangrui, Li, Jian, Dou, Guifang, Gan, Hui, Han, Peng, Du, Lina, Gu, Ruolan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254320/ https://www.ncbi.nlm.nih.gov/pubmed/37298919 http://dx.doi.org/10.3390/molecules28114441 |
Ejemplares similares
-
Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection
por: Li, Jian, et al.
Publicado: (2022) -
Pharmacological Effects and Clinical Prospects of Cepharanthine
por: Liang, Di, et al.
Publicado: (2022) -
Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation
por: Chen, Guangrui, et al.
Publicado: (2023) -
Pharmacological Activity of Cepharanthine
por: Liu, Ke, et al.
Publicado: (2023) -
Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis
por: Han, Xiaoxuan, et al.
Publicado: (2023)